A blood test that can detect many different types of cancer at the same time has long been a goal in cancer screening. In a new article in The Lancet, researchers caution against the widespread use of such tests before there is evidence that they actually lead to better health outcomes.
News
Professor Thomas Rösch, a leading German gastroenterologist and internationally recognized expert in interventional endoscopy, will join Clinical Effectiveness Research Group at the University of Oslo as a visiting professor for the 2026–2027 academic year.
Researchers in the EU-OperA project have published a paper on the legal implications of AI-related deskilling in clinical practice. The authors are Sara Gerke, Cesare Hassan, and Yuichi Mori, all work package leaders in the EU-OperA project.
Professor Yuichi Mori was in January 2026 appointed Co-Editor-in-Chief at the world's leading medical journal Endocopy.
Postdoctoral fellow at the Clinical Effectiveness Research Group, Anna Macios, was in January 2026 appointed Statistical Advisor at Endoscopy, the world's leading medical journal in endoscopy.
A new international guideline explains how artificial intelligence (AI) should be used in gastrointestinal (GI) endoscopy so patients get the benefits without added risks. Members of the OperA project — led by the Clinical Effectiveness Research Group at the University of Oslo — coordinated a global expert panel to produce the recommendations.
The ACCEPT team, part of the UiO OperA EU project, published a paper this week in the Lancet Gastroenterology and Hepatology that may generate controversy in the field of AI and colonoscopy.
PhD fellow Natalie Halvorsen published a paper on AI-assisted colonoscopy in this week's Endoscopy journal. The paper investigates the cost-effectiveness of leaving harmless polyps in the colon when adding AI as a decision-making tool.
In The Lancet Gastroenterology & Hepatology, Kate Wooldrage and colleagues present an update about the long-term effects of sigmoidoscopy on colorectal cancer incidence and mortality. Professor Michael Bretthauer and assoc. prof. Nastazja Pilonis dive deeper into the matter in a linked editorial.
Professor Yuichi Mori at the Clinical Effectiveness Research Group joins leading scientific journal Endoscopy as co-editor.
This years’ international conference by the European Society of Gastrointestinal Endoscopy (ESGE) had several highlights for the Clinical Effectiveness Research Group; presentation of groundbreaking research, an award, and TV shows.
Work package 1 of the EU-funded OperA project, the ACCEPT trial, reaches 10 000 inclusions this month. ACCEPT is a large-scale randomised trial investigating how the use of artificial intelligence (AI) during colonoscopy affects the cancer prevention effect.
Professor and gastroenterologist Michael Bretthauer wins the UEG Research Prize 2023. The prize is awarded to active, well-established senior researchers at the height of their active career, whose science has had a crucial impact on digestive health.
A new, large scale systematic review and meta analysis found that AI tool used in colonoscopy increased the endoscopist's ability to detect colorectal polyps.
Relative effects of treatments are often described in patient encounters, scientific journals, and mass media, although used alone to guide decision making they are insufficient and potentially misleading
Professor and gastroenterologist Michael Bretthauer is awarded the UEG Research Prize 2023, a prestigious honor given by the leading authority for gastroenterology and digestive health in Europe.
The new EU-funded flagship project presented project partners and work packages on September 13. OperA is a 5-year project to improve colorectal cancer care by artificial intelligence.
Dr. Yuichi Mori at the Clinical Effectiveness Research Group will lead a large new research project that aims to find solutions for clinical validation of artificial intelligence. The goal is to improve the diagnosis and therapy of colorectal cancer and polyps.
Public health mitigation measures such as social distancing, closing training centers and wearing face masks have been used during the Covid-19 pandemic. However, the benefits and harms of these measures are poorly understood.
There is great interest in artificial intelligence (AI) in health care. A recent paper in Gastroenterology discusses important issues when introducing new technology in medicine.
Dr. Yuichi Mori, postdoctoral fellow at Clinical effectiveness research group, receives the prestigeous EU Grant the Marie Skłodowska-Curie Actions fellowship.
Saturday The New York Times interviewed Mette Kalager and Michael Bretthauer in the article "Did closing schools actually help?" Read the article and find out.
Yuichi Mori, MD, PhD joins the Clinical effectiveness research group as Postdoctoral Fellow. Dr. Mori moves from Showa University Northern Yokohama Hospital in Japan to join the group in Oslo.
In an essay published this week on the World Economic Forum's News Agenda, UiO researcher Ishita Barua explains why we should look to Finland when planning for future success.
The prestigious journal Annals of Internal Medicine published February 19, 2019 two articles on the EU's new data protection regulation (GDPR). In both articles, Norwegian researchers and lawyers are central.